Brucellosis : Emerging and Re-Emerging Zoonosis

More than 500,000 human cases of brucellosis are reported each year, with Brucella melitensis being the primary cause. It is still one of the most prevalent zoonotic illnesses in the world. The CDC has categorized the bacterial pathogen as a category (B) disease, meaning that it possesses the potential to evolve into a bioweapon. It is thought that the most prevalent infections obtained in laboratories are Brucella species. The emergence or reappearance of new foci causes brucellosis to constantly shift in geographic distribution. Animals and humans are affected by the disease everywhere, with the exception of nations where bovine brucellosis has been completely eradicated. Due to brucellosis, there are significant economic losses incurred globally in both animal production and human health. All of the region’s countries have recorded cases of leishmaniasis, hepatitis A virus (HAV), and hepatitis E virus (HEV). Dengue fever, H5N1, Chikungunya, and Crimean Congo hemorrhagic fever (CCHF) have all been spreading geographically and in quantity as well as in frequency. Public health is still concerned about Middle East respiratory syndrome (MERS), which was first discovered in this area in 2012. In certain of the countries, poliomyelitis, leishmaniasis, cholera, and diphtheria control are difficult to maintain. Furthermore, just a few of the region’s nations are home to Rift Valley fever (RVF) and Alkhurma hemorrhagic fever (AHF). Furthermore, not much is known about the actual state of tularemia, Q fever, and the plague. In conclusion, EIDs and RIDs are widespread in the majority of the region’s nations and may continue to spread there. Enhancing regional capacities and capabilities is essential for both preventing disease outbreaks and providing sufficient resources and expertise to contain them.